 | |
- close
- close
|
Globe Newswire
Oct 26
Comment
PALATINE, Ill., Oct. 26, 2009 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) (the "Company" or "Acura") today reported a third quarter 2009 net loss of $4.0 million or $0.09 per share compared to net income of $3.1 million, or $0.06
Stock Blog Hub
Sep 4
Comment
King Pharmaceuticals, Inc. (KG) and Acura Pharmaceuticals, Inc. (ACUR) recently met with the U.S. Food and Drug Administration (FDA) to discuss the agency’s response to the New Drug Application (NDA) for Acurox (oxycodone HCl and niacin).
The...
FierceBiotech
Sep 4
Comment
Acura Pharmaceuticals and King Pharmaceuticals, partners on drug Acurox, may be able to get the pain drug through an FDA review without more clinical data. After a meeting on Wednesday, the companies said the FDA will not require new clinical...
StreetInsider.com
Sep 3
Comment
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Acura+Pharmaceuticals+%28ACUR%29+and+King+Pharmaceuticals+%28KG%29+Provide+Update+on+Acurox+NDA/4922477.html for the full story.
StreetInsider.com
Jul 2
Comment
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Acura+%28ACUR%29+%26+King+Pharmaceuticals+%28KG%29+Receive+Complete+Response+Letter+From+FDA+for+Acurox+/4769657.html for the full story.
Bloomberg
Jul 1
Comment
Tylenol, a 50-year-old staple of
household medicine cabinets, and Vicodin, the most prescribed
drug in the U.S., may face new restrictions because of the risk
of liver damage tied to the ingredient acetaminophen.
Bloomberg
Jun 23
Comment
(Update1) King Pharmaceuticals Inc., the
drugmaker betting its future on safer painkillers, and Acura
Pharmaceuticals Inc. said U.S. regulators will probably delay a
decision on whether to approve their Acurox tablets.
MarketWatch
Jun 23
Comment
Shares of Acura Pharmaceuticals tanked almost 30% on Tuesday after the company said that based on preliminary communication with the Food and Drug Administration, it does not believe its product Acurox will be approved by the agency's decision...
StreetInsider.com
Jun 23
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Acura+Pharma+%28ACUR%29+Receives+Preliminary+Review+Letter+from+FDA+Related+to+NDA+for+Acurox%28r%29/4748950.html for the full story.
Suggest other news sources for this topic
Thank you for your suggestion
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
ACUR AT A GLANCE
References
| ||||||
|
|
